{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:00:11Z","timestamp":1792800011865,"version":"4.5.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T00:00:00Z","timestamp":1765497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82305297"],"award-info":[{"award-number":["82305297"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82405457"],"award-info":[{"award-number":["82405457"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Suzhou Science and Technology Development Plan (Basic Research-Medical Application Basic Research) Project","award":["SYW2024126"],"award-info":[{"award-number":["SYW2024126"]}]},{"name":"Suzhou Science and Technology Development Plan (Basic Research-Medical Application Basic Research) Project","award":["SKY2023218"],"award-info":[{"award-number":["SKY2023218"]}]},{"name":"Gusu Health Talents Program Training Project in Suzhou","award":["GSWS2022082"],"award-info":[{"award-number":["GSWS2022082"]}]},{"name":"Gusu Health Talents Program Training Project in Suzhou","award":["GSWS2023116"],"award-info":[{"award-number":["GSWS2023116"]}]},{"name":"Suzhou Key Medical Discipline","award":["SZXK202518"],"award-info":[{"award-number":["SZXK202518"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"DOI":"10.1186\/s13048-025-01889-8","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T10:34:53Z","timestamp":1765535693000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Integrative multi-omics analysis of druggable genes for therapeutic target identification in polycystic ovary syndrome"],"prefix":"10.1186","volume":"18","author":[{"given":"Dan","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wansu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingxia","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiudao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,12]]},"reference":[{"key":"1889_CR1","doi-asserted-by":"publisher","DOI":"10.1177\/2633494120911038","volume":"14","author":"YV Louwers","year":"2020","unstructured":"Louwers YV, Laven JSE. Characteristics of polycystic ovary syndrome throughout life. Ther Adv Reprod Health. 2020;14:2633494120911038.","journal-title":"Ther Adv Reprod Health"},{"key":"1889_CR2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","volume":"22","author":"AH Balen","year":"2016","unstructured":"Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN, et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Hum Reprod Update. 2016;22:687\u2013708.","journal-title":"Hum Reprod Update"},{"key":"1889_CR3","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.tem.2024.10.005","volume":"36","author":"H Chen","year":"2025","unstructured":"Chen H, Simons PIHG, Brouwers MCGJ. Is cardiovascular disease in PCOS driven by MASLD? Trends Endocrinol Metab. 2025;36:389\u201391.","journal-title":"Trends Endocrinol Metab"},{"key":"1889_CR4","doi-asserted-by":"publisher","first-page":"2439","DOI":"10.1007\/s10815-022-02625-7","volume":"39","author":"S Siddiqui","year":"2022","unstructured":"Siddiqui S, Mateen S, Ahmad R, Moin S. A brief insight into the etiology, genetics, and immunology of polycystic ovarian syndrome (PCOS). J Assist Reprod Genet. 2022;39:2439\u201373.","journal-title":"J Assist Reprod Genet"},{"key":"1889_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.5582\/ddt.2024.01003","volume":"18","author":"J Wang","year":"2024","unstructured":"Wang J, Li L, Zhou J, Pan X, Qi Q, Sun H, et al. Yishen Huatan Huoxue Decoction and Quercetin ameliorate decidualization dysfunction in polycystic ovary syndrome: a comprehensive investigation combining clinical trial and experimental studies. Drug Discov Ther. 2024;18:117\u201329.","journal-title":"Drug Discov Ther"},{"key":"1889_CR6","first-page":"89","volume":"13","author":"R McDonnell","year":"2017","unstructured":"McDonnell R, Hart RJ. Pregnancy-related outcomes for women with polycystic ovary syndrome. Womens Health. 2017;13:89\u201397.","journal-title":"Womens Health"},{"key":"1889_CR7","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1556\/OH.2013.29589","volume":"154","author":"L S\u00e1godi","year":"2013","unstructured":"S\u00e1godi L, Kiss-T\u00f3th E, Barkai L. [Role of genetic and environmental factors in the development of polycystic ovary syndrome]. Orv Hetil. 2013;154:650\u20137.","journal-title":"Orv Hetil"},{"key":"1889_CR8","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1093\/ije\/29.4.722","volume":"29","author":"S Greenland","year":"2000","unstructured":"Greenland S. An introduction to instrumental variables for epidemiologists. Int J Epidemiol. 2000;29:722\u20139.","journal-title":"Int J Epidemiol"},{"key":"1889_CR9","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian randomization. JAMA. 2017;318:1925\u20136.","journal-title":"JAMA"},{"key":"1889_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-024-02848-5","volume":"25","author":"Z Liu","year":"2024","unstructured":"Liu Z, Peng Z, Lin H, Zhou K, Liang L, Cao J, et al. Identifying potential drug targets for idiopathic pulmonary fibrosis: a Mendelian randomization study based on the druggable genes. Respir Res. 2024;25:217.","journal-title":"Respir Res"},{"issue":"24","key":"1889_CR11","first-page":"00492","volume":"S2090\u20131232","author":"C Zhang","year":"2024","unstructured":"Zhang C, Li Y, Wang Y, Hu S, Liu Y, Liang X, et al. Genetic associations of metabolic factors and therapeutic drug targets with polycystic ovary syndrome. J Adv Res. 2024;S2090\u20131232(24):00492\u20132.","journal-title":"J Adv Res"},{"key":"1889_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02515-8","volume":"24","author":"X Ma","year":"2025","unstructured":"Ma X, Ding L, Li S, Fan Y, Wang X, Han Y, et al. Druggable genome-wide Mendelian randomization identifies therapeutic targets for metabolic dysfunction-associated steatotic liver disease. Lipids Health Dis. 2025;24:113.","journal-title":"Lipids Health Dis"},{"key":"1889_CR13","doi-asserted-by":"crossref","unstructured":"Hong Y, Li J, Du Z, Xu N, Yang Q, Zhou J-X et al. Genomic evidence based on EQTL data implicates endocrine disruptors as environmental risk factors for Estrogen receptor-positive breast cancer. Int J Surg. 2025;111:5664-5674 .","DOI":"10.1097\/JS9.0000000000002642"},{"key":"1889_CR14","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s41588-021-00913-z","volume":"53","author":"U V\u00f5sa","year":"2021","unstructured":"V\u00f5sa U, Claringbould A, Westra H-J, Bonder MJ, Deelen P, Zeng B, et al. Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression. Nat Genet. 2021;53:1300\u201310.","journal-title":"Nat Genet"},{"key":"1889_CR15","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411679","volume":"12","author":"G Wang","year":"2025","unstructured":"Wang G, Mao W, Zhang Y, Yang H, Zhu M, Li Y, et al. Multiomics and systematic analyses reveal the roles of hemoglobin and the HIF-1 pathway in polycystic ovary syndrome. Adv Sci. 2025;12:e2411679.","journal-title":"Adv Sci"},{"key":"1889_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aag1166","volume":"9","author":"C Finan","year":"2017","unstructured":"Finan C, Gaulton A, Kruger FA, Lumbers RT, Shah T, Engmann J, et al. The druggable genome and support for target identification and validation in drug development. Sci Transl Med. 2017;9:eaag1166.","journal-title":"Sci Transl Med"},{"key":"1889_CR17","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","volume":"48","author":"Z Zhu","year":"2016","unstructured":"Zhu Z, Zhang F, Hu H, Bakshi A, Robinson MR, Powell JE, et al. Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets. Nat Genet. 2016;48:481\u20137.","journal-title":"Nat Genet"},{"key":"1889_CR18","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"GTEx Consortium","year":"2020","unstructured":"GTEx Consortium. The GTEx consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318\u201330.","journal-title":"Science"},{"key":"1889_CR19","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1038\/s41588-021-00923-x","volume":"53","author":"JL Min","year":"2021","unstructured":"Min JL, Hemani G, Hannon E, Dekkers KF, Castillo-Fernandez J, Luijk R, et al. Genomic and phenotypic insights from an atlas of genetic effects on DNA methylation. Nat Genet. 2021;53:1311\u201321.","journal-title":"Nat Genet"},{"key":"1889_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1004383","volume":"10","author":"C Giambartolomei","year":"2014","unstructured":"Giambartolomei C, Vukcevic D, Schadt EE, Franke L, Hingorani AD, Wallace C, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10:e1004383.","journal-title":"PLoS Genet"},{"key":"1889_CR21","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13040885","volume":"13","author":"S Jiang","year":"2025","unstructured":"Jiang S, Fan F, Li Q, Zuo L, Xu A, Sun C. Therapeutic target discovery for multiple myeloma: identifying druggable genes via Mendelian randomization. Biomedicines. 2025;13:885.","journal-title":"Biomedicines"},{"key":"1889_CR22","doi-asserted-by":"publisher","first-page":"10611","DOI":"10.3390\/ijms241310611","volume":"24","author":"RA Harris","year":"2023","unstructured":"Harris RA, McAllister JM, Strauss JF, Single-Cell RNA-S. Identifies pathways and genes contributing to the hyperandrogenemia associated with polycystic ovary syndrome. Int J Mol Sci. 2023;24:10611.","journal-title":"Int J Mol Sci"},{"key":"1889_CR23","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/jez.a.307","volume":"305","author":"CJ Mattingly","year":"2006","unstructured":"Mattingly CJ, Rosenstein MC, Colby GT, Forrest JN, Boyer JL. The comparative toxicogenomics database (CTD): a resource for comparative toxicological studies. J Exp Zool Comp Exp Biol. 2006;305:689\u201392.","journal-title":"J Exp Zool Comp Exp Biol"},{"key":"1889_CR24","doi-asserted-by":"publisher","first-page":"W159","DOI":"10.1093\/nar\/gkac394","volume":"50","author":"Y Liu","year":"2022","unstructured":"Liu Y, Yang X, Gan J, Chen S, Xiao Z-X, Cao Y. CB-dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting. Nucleic Acids Res. 2022;50:W159-64.","journal-title":"Nucleic Acids Res"},{"key":"1889_CR25","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9 V, Steri M, Sidore C, Marongiu M, Serra V, Olla S, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52:1036\u201345.","journal-title":"Nat Genet"},{"key":"1889_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1470283","volume":"15","author":"H Deng","year":"2024","unstructured":"Deng H, Chen Y, Xing J, Zhang N, Xu L. Systematic low-grade chronic inflammation and intrinsic mechanisms in polycystic ovary syndrome. Front Immunol. 2024;15:1470283.","journal-title":"Front Immunol"},{"key":"1889_CR27","doi-asserted-by":"publisher","first-page":"6333","DOI":"10.1523\/JNEUROSCI.20-17-06333.2000","volume":"20","author":"Z Pang","year":"2000","unstructured":"Pang Z, Zuo J, Morgan JI. Cbln3, a novel member of the precerebellin family that binds specifically to Cbln1. J Neurosci. 2000;20:6333\u20139.","journal-title":"J Neurosci"},{"key":"1889_CR28","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1111\/j.1460-9568.2007.05361.x","volume":"25","author":"T Iijima","year":"2007","unstructured":"Iijima T, Miura E, Matsuda K, Kamekawa Y, Watanabe M, Yuzaki M. Characterization of a transneuronal cytokine family Cbln\u2013regulation of secretion by heteromeric assembly. Eur J Neurosci. 2007;25:1049\u201357.","journal-title":"Eur J Neurosci"},{"key":"1889_CR29","doi-asserted-by":"publisher","first-page":"9327","DOI":"10.1128\/MCB.01161-06","volume":"26","author":"D Bao","year":"2006","unstructured":"Bao D, Pang Z, Morgan MA, Parris J, Rong Y, Li L, et al. Cbln1 is essential for interaction-dependent secretion of Cbln3. Mol Cell Biol. 2006;26:9327\u201337.","journal-title":"Mol Cell Biol"},{"key":"1889_CR30","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1111\/j.1460-9568.2007.05913.x","volume":"26","author":"P Wei","year":"2007","unstructured":"Wei P, Smeyne RJ, Bao D, Parris J, Morgan JI. Mapping of Cbln1-like immunoreactivity in adult and developing mouse brain and its localization to the endolysosomal compartment of neurons. Eur J Neurosci. 2007;26:2962\u201378.","journal-title":"Eur J Neurosci"},{"key":"1889_CR31","first-page":"411","volume":"15","author":"M Rucinski","year":"2005","unstructured":"Rucinski M, Albertin G, Spinazzi R, Ziolkowska A, Nussdorfer GG, Malendowicz LK. Cerebellin in the rat adrenal gland: gene expression and effects of CER and [des-Ser1]CER on the secretion and growth of cultured adrenocortical cells. Int J Mol Med. 2005;15:411\u20135.","journal-title":"Int J Mol Med"},{"key":"1889_CR32","first-page":"113","volume":"23","author":"M Rucinski","year":"2009","unstructured":"Rucinski M, Malendowicz LK. Precerebellin-related genes and precerebellin 1 peptide in endocrine glands of the rat - pattern of their expression. Int J Mol Med. 2009;23:113\u20139.","journal-title":"Int J Mol Med"},{"key":"1889_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.regpep.2009.05.010","volume":"157","author":"MZ Strowski","year":"2009","unstructured":"Strowski MZ, Kaczmarek P, Mergler S, Wiedenmann B, Domin D, Szwajkowski P, et al. Insulinostatic activity of cerebellin\u2013evidence from in vivo and in vitro studies in rats. Regul Pept. 2009;157:19\u201324.","journal-title":"Regul Pept"},{"key":"1889_CR34","first-page":"553","volume":"22","author":"M Rucinski","year":"2008","unstructured":"Rucinski M, Zok A, Guidolin D, De Caro R, Malendowicz LK. Expression of precerebellins in cultured rat calvaria osteoblast-like cells. Int J Mol Med. 2008;22:553\u20138.","journal-title":"Int J Mol Med"},{"key":"1889_CR35","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5653\/cerm.2017.44.1.33","volume":"44","author":"AA Ersahin","year":"2017","unstructured":"Ersahin AA, Acet M, Ersahin SS, Acet T, Yardim M, Kenanoglu O, et al. Follicular fluid cerebellin and betatrophin regulate the metabolic functions of growing follicles in polycystic ovary syndrome. Clin Exp Reprod Med. 2017;44:33\u20139.","journal-title":"Clin Exp Reprod Med"},{"key":"1889_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.937309","volume":"13","author":"X Yao","year":"2022","unstructured":"Yao X, Wang X. Bioinformatics searching of diagnostic markers and immune infiltration in polycystic ovary syndrome. Front Genet. 2022;13:937309.","journal-title":"Front Genet"},{"key":"1889_CR37","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.nefroe.2022.11.015","volume":"43","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Fang H, Zhu Z. NRBP1 modulates uric acid transporter ABCG2 expression by activating the Wnt\/\u03b2-catenin pathway in HK-2 cells. Nefrolog\u00eda (English Edition). 2023;43:204\u201312.","journal-title":"Nefrolog\u00eda (English Edition)"},{"key":"1889_CR38","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1038\/s41388-023-02594-w","volume":"42","author":"X Yang","year":"2023","unstructured":"Yang X, Cruz MI, Nguyen EV, Huang C, Schittenhelm RB, Luu J, et al. The pseudokinase NRBP1 activates Rac1\/Cdc42 via P-Rex1 to drive oncogenic signalling in triple-negative breast cancer. Oncogene. 2023;42:833\u201347.","journal-title":"Oncogene"},{"key":"1889_CR39","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70100","volume":"13","author":"A Zhang","year":"2024","unstructured":"Zhang A, Peng S, Sun S, Ye S, Zhao Y, Wu Q. NRBP1 promotes malignant phenotypes of glioblastoma by regulating PI3K\/Akt activation. Cancer Med. 2024;13:e70100.","journal-title":"Cancer Med"},{"key":"1889_CR40","first-page":"3721","volume":"8","author":"H Wei","year":"2015","unstructured":"Wei H, Wang H, Ji Q, Sun J, Tao L, Zhou X. NRBP1 is downregulated in breast cancer and NRBP1 overexpression inhibits cancer cell proliferation through Wnt\/\u03b2-catenin signaling pathway. Onco Targets Ther. 2015;8:3721\u201330.","journal-title":"Onco Targets Ther"},{"key":"1889_CR41","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13259","volume":"23","author":"C Yang","year":"2022","unstructured":"Yang C, Zhang X, Gao C, Du K, Liu Y. Nrbp1 negatively regulates SALL4 to reduce the invasion and migration, promote apoptosis and increase the sensitivity to chemotherapy drugs of breast cancer cells. Oncol Lett. 2022;23:139.","journal-title":"Oncol Lett"},{"key":"1889_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-017-0401-z","volume":"9","author":"Z Zhu","year":"2017","unstructured":"Zhu Z, Meng W, Liu P, Zhu X, Liu Y, Zou H. DNA hypomethylation of a transcription factor binding site within the promoter of a gout risk gene NRBP1 upregulates its expression by inhibition of TFAP2A binding. Clin Epigenetics. 2017;9:99.","journal-title":"Clin Epigenetics"},{"key":"1889_CR43","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1152\/physiolgenomics.00193.2004","volume":"20","author":"JR Wood","year":"2005","unstructured":"Wood JR, Nelson-Degrave VL, Jansen E, McAllister JM, Mosselman S, Strauss JF. Valproate-induced alterations in human theca cell gene expression: clues to the association between valproate use and metabolic side effects. Physiol Genomics. 2005;20:233\u201343.","journal-title":"Physiol Genomics"},{"key":"1889_CR44","doi-asserted-by":"publisher","first-page":"26380","DOI":"10.1074\/jbc.M300688200","volume":"278","author":"JR Wood","year":"2003","unstructured":"Wood JR, Nelson VL, Ho C, Jansen E, Wang CY, Urbanek M, et al. The molecular phenotype of polycystic ovary syndrome (PCOS) theca cells and new candidate PCOS genes defined by microarray analysis. J Biol Chem. 2003;278:26380\u201390.","journal-title":"J Biol Chem"},{"key":"1889_CR45","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/s41380-021-01377-7","volume":"27","author":"W Yao","year":"2022","unstructured":"Yao W, Cao Q, Luo S, He L, Yang C, Chen J, et al. Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine. Mol Psychiatry. 2022;27:1618\u201329.","journal-title":"Mol Psychiatry"},{"key":"1889_CR46","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/humrep\/del371","volume":"22","author":"R Wu","year":"2007","unstructured":"Wu R, Fujii S, Ryan NK, Van der Hoek KH, Jasper MJ, Sini I, et al. Ovarian leukocyte distribution and cytokine\/chemokine mRNA expression in follicular fluid cells in women with polycystic ovary syndrome. Hum Reprod. 2007;22:527\u201335.","journal-title":"Hum Reprod"},{"key":"1889_CR47","doi-asserted-by":"publisher","DOI":"10.3390\/life13041010","volume":"13","author":"M Moulana","year":"2023","unstructured":"Moulana M. Androgen-induced cardiovascular risk in polycystic ovary syndrome: the role of T lymphocytes. Life. 2023;13:1010.","journal-title":"Life"},{"key":"1889_CR48","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jri.2011.09.003","volume":"92","author":"ME Solano","year":"2011","unstructured":"Solano ME, Sander VA, Ho H, Motta AB, Arck PC. Systemic inflammation, cellular influx and up-regulation of ovarian VCAM-1 expression in a mouse model of polycystic ovary syndrome (PCOS). J Reprod Immunol. 2011;92:33\u201344.","journal-title":"J Reprod Immunol"},{"key":"1889_CR49","doi-asserted-by":"publisher","first-page":"217","DOI":"10.4049\/jimmunol.2200105","volume":"209","author":"C Harly","year":"2022","unstructured":"Harly C, Robert J, Legoux F, Lantz O. \u0393\u03b4 T, NKT, and MAIT cells during evolution: redundancy or specialized functions? J Immunol. 2022;209:217\u201325.","journal-title":"J Immunol"},{"key":"1889_CR50","doi-asserted-by":"publisher","first-page":"807","DOI":"10.2147\/IJWH.S508352","volume":"17","author":"X-L Wang","year":"2025","unstructured":"Wang X-L, He Y-F, Chen S-K, Cheng J, Wu X-M. Dissecting causal relationships between immune cells, plasma metabolites, and PCOS: evidence from mediating Mendelian randomization analysis. Int J Womens Health. 2025;17:807\u201323.","journal-title":"Int J Womens Health"},{"key":"1889_CR51","doi-asserted-by":"publisher","first-page":"15507","DOI":"10.1080\/07391102.2023.2190411","volume":"41","author":"F Koohnavard","year":"2023","unstructured":"Koohnavard F, Ahmadi K, Eftekhar E, Edalatmanesh MA. Computational screening of FDA-approved drugs to identify potential aromatase receptor inhibitors for polycystic ovary syndrome. J Biomol Struct Dyn. 2023;41:15507\u201319.","journal-title":"J Biomol Struct Dyn"},{"key":"1889_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.crtox.2022.100070","volume":"3","author":"GA Perono","year":"2022","unstructured":"Perono GA, Petrik JJ, Thomas PJ, Holloway AC. The effects of polycyclic aromatic compounds (PACs) on mammalian ovarian function. Curr Res Toxicol. 2022;3:100070.","journal-title":"Curr Res Toxicol"},{"key":"1889_CR53","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3109\/09513590.2013.871517","volume":"30","author":"A Rutkowska","year":"2014","unstructured":"Rutkowska A, Racho\u0144 D. Bisphenol A (BPA) and its potential role in the pathogenesis of the polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2014;30:260\u20135.","journal-title":"Gynecol Endocrinol"},{"key":"1889_CR54","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1080\/09513590.2017.1405931","volume":"34","author":"Y Hu","year":"2018","unstructured":"Hu Y, Wen S, Yuan D, Peng L, Zeng R, Yang Z, et al. The association between the environmental endocrine disruptor bisphenol A and polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol. 2018;34:370\u20137.","journal-title":"Gynecol Endocrinol"},{"key":"1889_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01410-y","volume":"22","author":"J Shi","year":"2024","unstructured":"Shi J, Hu K-L, Li X-X, Ge Y-M, Yu X-J, Zhao J. Bisphenol a downregulates GLUT4 expression by activating Aryl hydrocarbon receptor to exacerbate polycystic ovary syndrome. Cell Commun Signal. 2024;22:28.","journal-title":"Cell Commun Signal"},{"key":"1889_CR56","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1080\/09513590.2017.1418852","volume":"34","author":"M Stracquadanio","year":"2018","unstructured":"Stracquadanio M, Ciotta L, Palumbo MA. Effects of myo-inositol, gymnemic acid, and L-methylfolate in polycystic ovary syndrome patients. Gynecol Endocrinol. 2018;34:495\u2013501.","journal-title":"Gynecol Endocrinol"},{"key":"1889_CR57","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2337\/dc09-1516","volume":"33","author":"S Palomba","year":"2010","unstructured":"Palomba S, Falbo A, Giallauria F, Russo T, Tolino A, Zullo F, et al. Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome. Diabetes Care. 2010;33:246\u201351.","journal-title":"Diabetes Care"},{"key":"1889_CR58","doi-asserted-by":"publisher","first-page":"4354","DOI":"10.1210\/en.2012-1145","volume":"153","author":"A Hirsch","year":"2012","unstructured":"Hirsch A, Hahn D, Kempn\u00e1 P, Hofer G, Nuoffer J-M, Mullis PE, et al. Metformin inhibits human androgen production by regulating steroidogenic enzymes HSD3B2 and CYP17A1 and complex I activity of the respiratory chain. Endocrinology. 2012;153:4354\u201366.","journal-title":"Endocrinology"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01889-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-025-01889-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-025-01889-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T12:03:43Z","timestamp":1765541023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13048-025-01889-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,12]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1889"],"URL":"https:\/\/doi.org\/10.1186\/s13048-025-01889-8","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,12]]},"assertion":[{"value":"13 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants provided informed written consent, and all studies were reviewed and approved by the institutional ethical review boards of the respective institutions. Thus, no additional ethical approvals or licenses were required for this MR study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"293"}}